- Home
- RZLT vs WALD Comparison
RZLT vs WALD Comparison
Compare RZLT & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- WALD
- Stock Information
- Founded
- RZLT 2010
- WALD 1988
- Country
- RZLT United States
- WALD United States
- Employees
- RZLT N/A
- WALD N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- RZLT Health Care
- WALD Consumer Discretionary
- Exchange
- RZLT Nasdaq
- WALD Nasdaq
- Market Cap
- RZLT 361.3M
- WALD 306.3M
- IPO Year
- RZLT N/A
- WALD 2021
- Fundamental
- Price
- RZLT $7.20
- WALD $1.62
- Analyst Decision
- RZLT Strong Buy
- WALD Strong Buy
- Analyst Count
- RZLT 5
- WALD 5
- Target Price
- RZLT $12.50
- WALD $4.96
- AVG Volume (30 Days)
- RZLT 680.6K
- WALD 528.4K
- Earning Date
- RZLT 09-18-2025
- WALD 11-11-2025
- Dividend Yield
- RZLT N/A
- WALD N/A
- EPS Growth
- RZLT N/A
- WALD N/A
- EPS
- RZLT N/A
- WALD N/A
- Revenue
- RZLT N/A
- WALD $273,868,000.00
- Revenue This Year
- RZLT N/A
- WALD $10.37
- Revenue Next Year
- RZLT N/A
- WALD $14.37
- P/E Ratio
- RZLT N/A
- WALD N/A
- Revenue Growth
- RZLT N/A
- WALD 25.55
- 52 Week Low
- RZLT $2.22
- WALD $1.50
- 52 Week High
- RZLT $7.46
- WALD $4.74
- Technical
- Relative Strength Index (RSI)
- RZLT 78.84
- WALD 38.09
- Support Level
- RZLT $6.23
- WALD $1.50
- Resistance Level
- RZLT $6.64
- WALD $1.79
- Average True Range (ATR)
- RZLT 0.30
- WALD 0.17
- MACD
- RZLT 0.05
- WALD 0.01
- Stochastic Oscillator
- RZLT 86.56
- WALD 20.00
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.